Supplies - 64779-2019

11/02/2019    S29    - - Supplies - Voluntary ex ante transparency notice - Negotiated procedure without a call for competition 

United Kingdom-Salisbury: Services related to water pollution

2019/S 029-064779

Voluntary ex ante transparency notice

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority/entity

I.1)Name and addresses
Public Health England
Manor Farm Road, Porton Down
Salisbury
SP2 0QT
United Kingdom
Telephone: +44 2076548000
E-mail: Mercy.Mashem@phe.gov.uk
NUTS code: UK

Internet address(es):

Main address: https://www.gov.uk/government/organisations/public-health-england

I.4)Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Provision of a High Throughput Bartonella Platform and Chemiluminescent Immunoassays

II.1.2)Main CPV code
90733000
II.1.3)Type of contract
Supplies
II.1.4)Short description:

Public Health England (PHE) is planning to award a contract for the provision of a chemiluminescent processor and accompanying serology kits for detecting Bartonella henselae IgG and IgM antibodies in human serum and plasma to Launch Diagnostic Ltd.

PHE believes that the Vircila automated processor platform is currently the only CE-certified IVDD diagnostic device in the market capable of performing the required indirect chemiluminescent Immunoassay to test for Bartonella henselae IgG and IgM antibodies in human serum and plasma.

II.1.6)Information about lots
This contract is divided into lots: no
II.1.7)Total value of the procurement (excluding VAT)
Value excluding VAT: 500 000.00 GBP
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)
II.2.3)Place of performance
NUTS code: UK
Main site or place of performance:

Porton Down.

II.2.4)Description of the procurement:

The PHE Rare and Imported Pathogens Laboratory intends to start a Bartonella serology testing service using a chemiluminescent enzyme immunoassay test and performed on compatible platform as a frontline diagnostic assay to test for the presence of Bartonella IgM and IgG antibodies. This process will utilise a full sample to automatic result processing and interpretation of results. The platform capabilities also provide for open configuration to enable additional non-manufacturer specific use and configuration for ELISA-based assays for human clinical samples for diagnostic use.

Bartonella serological detection by indirect fluorescent antibody (IFA) testing does not meet the laboratory requirement for full sample to automatic processing, but IFA technology may be considered by the laboratory at a later date in a subsequent tender.

II.2.5)Award criteria
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Negotiated procedure without prior publication
  • The products involved are manufactured purely for the purpose of research, experiment, study or development under the conditions stated in the directive
  • The works, supplies or services can be provided only by a particular economic operator for the following reason:
    • absence of competition for technical reasons
Explanation:

Following extensive market research, PHE believe that Viracell are the only supplier capable of meeting the requirements. Launch Diagnostics Ltd are the exclusive distributor of all Virecell products in UK. Other companies within the EU hold agreements with Vircell but can only sell products and enter tender submissions within their prescribed territory.

IV.1.3)Information about framework agreement
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

Section V: Award of contract/concession

V.2)Award of contract/concession
V.2.1)Date of contract award decision:
05/02/2019
V.2.2)Information about tenders
The contract has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractor/concessionaire
Launch Diagnostics Limited
02427295
1 Friar Street
Reading, Berkshire
RG1 1DA
United Kingdom
NUTS code: UK
The contractor/concessionaire will be an SME: no
V.2.4)Information on value of the contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: 500 000.00 GBP
V.2.5)Information about subcontracting
The contract/lot/concession is likely to be subcontracted

Section VI: Complementary information

VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
Public Health England (PHE)
London
United Kingdom
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained
VI.5)Date of dispatch of this notice:
06/02/2019